Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves first CIRM‑funded gene‑editing therapy for rare immune disorder
The FDA has granted approval to KRESLADI, a gene‑editing therapy from Rocket Pharmaceuticals that treats severe leukocyte adhesion deficiency‑I in children without a matching bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine (CIRM), highlighting the agency’s impact on translational research.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
The FDA’s recent safety alert warns that high‑dose levodopa/carbidopa regimens can provoke seizures when patients develop vitamin B6 deficiency. Fourteen post‑marketing cases, including two fatalities, involved doses exceeding 1,000 mg daily and featured focal‑onset seizures that generalized. Vitamin B6 supplementation halted seizures in every treated patient, prompting the agency to require label updates across all carbidopa/levodopa products. Clinicians are now advised to screen and monitor B6 status throughout therapy.
Kali Therapeutics has signed a license agreement with Sanofi granting the French giant exclusive worldwide rights to KT501, a next‑generation tri‑specific T‑cell engager aimed at B‑cell‑mediated autoimmune diseases. The deal provides Kali with $180 million in upfront and near‑term payments and...
Oryon Cell Therapies presented interim Phase 1b/2a data showing that its autologous dopaminergic neuron‑replacement therapy produced sustained motor improvements in Parkinson’s patients. Five participants experienced 29‑62% reductions in OFF‑state MDS‑UPDRS Part III scores over 6‑18 months, with continued gains beyond six months....
Gene therapies promise one‑time cures for diseases like sickle‑cell and inherited blindness, but their price tags—often $1 million to $3 million per patient—clash with the U.S. insurance model. More than half of new cell and gene therapies face coverage restrictions because insurers...
Lakia Jackson, 36, was sentenced to 60 months in federal prison for a Medicaid fraud scheme that siphoned $2.66 million intended for at‑risk pregnant women and young children in Wisconsin. She pleaded guilty to healthcare fraud and aggravated identity theft after...
Netherlands‑based Liqcreate has launched Separation Model, a dental photopolymer that embeds a non‑adhesive agent, removing the need for separate separating media in acrylic orthodontic and prosthetic workflows. The resin is compatible with most DLP, MSLA and laser 3‑D printers operating...
Private healthcare marketing is evolving from a standalone communications function into an integrated layer of the digital health stack, directly linked to EHRs, scheduling and telehealth platforms. This new model treats campaigns as dynamic demand‑orchestration tools that respond to real‑time...
A prospective study of 200 adults compared low‑dose photon‑counting CT (PCCT) with conventional energy‑integrating detector CT for lung cancer imaging. PCCT reduced effective radiation dose by 66% (1.36 mSv vs. 4.04 mSv) and iodine load by 27%, while adverse reactions fell to...
Community‑based healthcare is evolving from a peripheral add‑on to a primary delivery model, driven by decentralization, digital platforms, and value‑based economics. The approach embeds local clinics, health workers, and digital ecosystems to provide continuous, location‑specific care. Membership structures and managed...
Gut health research has moved from niche science to a core component of healthcare delivery. Recent FDA approval of Seres Therapeutics' Vowst and the rise of bioactive‑based microbiome products signal a shift toward industrialized, reproducible therapies. Companies across biotech, nutrition...
Henlius announced that China’s National Medical Products Administration (NMPA) has granted IND clearance for HLX18, a biosimilar of Opdivo (nivolumab), targeting resected solid tumours. The company also reported first‑patient dosing in Phase I trials for HLX17 (Keytruda biosimilar) and HLX13...
Xilio Therapeutics reported a strong cash position of $137.5 million, extending its runway to the end of 2027, and highlighted significant pipeline advances. The company plans to file an IND for its bispecific PD‑1/masked IL‑2 candidate XTX501 in mid‑2026 and start...
Telehealth has evolved from a supplemental channel into the primary interface for care delivery, driven by mature infrastructure and patient expectations. Mobile app development—especially Android due to its worldwide device penetration—has become the core conduit for patient access, provider coordination,...
A Washington man was awarded a $10 million jury verdict after emergency‑department physicians ordered the wrong imaging study, delaying treatment of a spinal epidural abscess. The misstep resulted in a 17‑hour wait, during which his paralysis progressed and became permanent. The...
Measles cases in the United States are climbing sharply, with 2025 recording over 2,200 infections—the highest in two decades—and 2026 already reporting nearly 1,500 cases across 27 states. The CDC has identified 14 new outbreaks this year, and the nation...
Physician executive Seleipiri Akobo recounts how generative AI rendered her as a white woman, and when her race was added, as a stereotypical Black superhero. The incident illustrates how AI models default to white norms and treat Black identities as...
Latent Labs unveiled Latent‑Y, an autonomous AI agent that designs therapeutic antibodies from natural‑language prompts. Powered by the Latent‑X2 generative model, the platform compresses weeks of expert work into hours and can run multiple design campaigns in parallel. In three...
Insmed announced that a Phase 3 trial showed adding its inhaled antibiotic Arikayce to standard therapy significantly improved respiratory symptoms and boosted culture conversion rates in patients with newly diagnosed mycobacterium avium complex (MAC) lung infection. The study met its primary...
The Independent Budget Office report shows Staten Island achieved the fastest advanced life support (ALS) EMS response in New York City in 2024, with 82% of calls answered within ten minutes. Across all boroughs, response times have slipped over the...
Avalo Therapeutics announced its 2025 financial results, reporting $98.3 million in cash and short‑term investments that should fund operations into 2028. Research and development expenses jumped to $50.1 million, driven by the Phase 2 LOTUS trial of abdakibart (AVTX‑009) for hidradenitis suppurativa. The...
Daymark Health, a Philadelphia‑based cancer‑care platform, announced the creation of a Clinical Advisory Board to steer its value‑based, full‑risk care strategy. The board brings together leading oncologists, health‑policy experts, patient advocates and former government officials, including Dr. Ezekiel Emanuel and...
Healthcare is the only industry where you can be assaulted on the job and still be expected to finish your shift. Emergency nurse Kristen Cline has spent 20 years on the front lines. In a recent conversation on The Podcast by...
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer [Dec 15, 2021] Schneider et al. Radovich @JCO_ASCO https://t.co/oJm6BJrMtA #bcsm #PrecisionMedicine
Pfizer and Valneva’s experimental Lyme vaccine cut the risk of infection by more than 70% in a late‑stage trial, offering a promising preventive tool for a disease that affects roughly 476,000 Americans annually. The study, however, missed its primary statistical...
Genome-Wide Associations [GWAS] and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors [Sep 20, 2010] Ingle et al. @DrWeinshilboum @JCO_ASCO https://t.co/1NJcXkWy8c #bcsm #Supponc
Assoc of Circulating Tumor DNA & Circulating Tumor Cells After Neoadjuvant Chemotherapy w/ Disease Recurrence in Pts w/ Triple-Negative Breast Cancer: BRE12-158 RCT [Jul 9, 2020] Radovich et al. @JAMAOnc https://t.co/XxH9kTT9d5 #bcsm #cactc #NCT02101385 https://t.co/kgV0yM2I1f
Connecticut Democrats advanced Senate Bill 3, a $200 million health‑care initiative aimed at expanding tax credits after the ACA subsidies lapsed. The bill extends premium subsidies to families earning up to 600 % of the federal poverty level and creates a state‑run...
Pfizer's phase 3 for its Lyme trial was supposed to be 18k patients -- but issues with a contractor at the start of the trial cut the size by a third, and @ky_lahucik + I reported a long time ago...
P7C3 is an activator of an enzyme that makes NAD called NAMPT. Cool that it’s working in a 🐁 model of AD 👏
HealthEquity, the largest U.S. health‑savings‑account administrator, announced record HSA sales and expanding margins in its March earnings call. The company credited the Trump‑era "One Big Beautiful" bill for broadening HSA eligibility, adding roughly 10 million new potential participants. Shortly after, HealthEquity...
A study published in #TheLancet Oncology reports a rise in bowel #cancer cases among people under 50 in 27 out of 50 countries over 10 years. Possible causes include obesity, gut bacteria, ultra-processed foods, and ... #healthcare #research https://t.co/Mjap7D8jtb
Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle There is a set up for drama here. $Valn $pfe Valneva stock is down 14% in premarket trading. https://t.co/WN0KOl4Nqh via @statnews
Apogee Therapeutics reported that its experimental long‑acting eczema biologic, zumilokibart, achieved sustained skin‑clearance in a mid‑stage trial. Seventy‑five percent of patients receiving the drug every three months and 85 % of those dosed every six months maintained an EASI‑75 response after...
IntraBio has filed a supplemental New Drug Application (sNDA) with the U.S. FDA seeking approval of Aqneursa (levacetylleucine) for Ataxia‑Telangiectasia (A‑T). The filing is supported by a Phase III trial that met its primary and key secondary endpoints and demonstrated a...
Serial entrepreneur Martin Varsavsky is launching Certuma, a startup aiming to create the first FDA‑approved AI doctor. The company raised $10 million in seed funding at a $60 million valuation and is targeting 25 low‑risk conditions such as UTIs and sore throats....
The paper highlights that fragmented, inequitable health‑care data hampers patient‑centred AI, limiting personalization and equity. It critiques three existing AI pathways and proposes Adaptive Machine Learning (AML) as a fourth, continuously updating models with real‑world, context‑sensitive data. AML rests on...
Recent research highlights three critical fronts in hospice and palliative care: a Community Hospice and Palliative Medicine (CHPM) fellowship at the University of Colorado is boosting mid‑career physicians' skills and confidence to address national workforce shortages; the Canadian PEACH program...
PointClickCare unveiled a next‑generation electronic health record tailored for practice groups, tightly integrated with its flagship post‑acute care platform used by over 30,000 organizations. The solution embeds AI‑driven Ambient Scribe and clinical risk insights directly into physician workflows, promising measurable...
NHS Supply Chain has formally committed to applying a new value‑based procurement methodology, co‑created with the Department of Health and Social Care, to all its purchasing activities. The framework, developed over three years, will be rolled out across England and...
Resmed’s sixth Global Sleep Survey of 30,000 respondents across 13 countries shows that 53% now rank sleep as the most important health behavior, ahead of diet and exercise. Yet more than half of participants report getting quality sleep only four...
Britain’s mid‑life adults (30‑59) now account for 56% of all private diagnostic scans, a six‑fold increase since 2022, driven largely by chronic pain and preventive health concerns. With NHS waiting lists exceeding two million and delays over six weeks, private...
A Dallas federal jury convicted former NFL player Keith J. Gray of orchestrating a $328 million Medicare fraud scheme that billed for unnecessary cardiovascular genetic tests. Gray, who owned Axis Professional Labs and Kingdom Health Laboratory, was found guilty of conspiracy,...
CareTria is launching an end-to-end patient support model that acts as a single point of contact, promising one‑call resolution and uninterrupted therapy access. The strategy blends AI‑driven automation with human interaction to handle routine tasks while preserving empathy for complex...
The FDA’s Rare Disease Evidence Principles (RDEP) introduce flexible trial designs, allowing sponsors to use natural‑history data and novel biomarkers as endpoints. These guidances aim to accelerate approvals for rare‑disease therapies while maintaining safety as a top priority. However, analysts...
Assured offers a software platform that combines AI‑driven automation with credentialing experts to streamline provider licensing, credentialing, and payer enrollment across multiple states. The service automates data collection, screen‑scrapes portals, and manages follow‑up, charging a base SaaS fee plus usage‑based...
Voters who cite affordability as their top worry are overwhelmingly pointing to health‑care costs, according to recent polling. The trend has prompted Democrats to reframe their health‑care narrative around price rather than access, using the issue to energize their base....
Galderma announced that the U.S. FDA has cleared Restylane Contour for the correction of temple hollowing in adults over 21, extending its existing cheek and mid‑face indications. Clinical studies demonstrated a 91% responder rate at three months, with efficacy persisting for...
Benjamin Landa, a nursing‑home owner nominated by Donald Trump for U.S. ambassador to Hungary, is facing a lawsuit from his own facility, Pinnacle Multicare Nursing and Rehabilitation Center, which seeks to block a HHS audit that identified at least $31.2 million...
Life‑sciences firms are confronting compressed validation timelines, tighter regulatory oversight and fragile supply chains, prompting a shift from cost‑driven to confidence‑driven site selection. Middlesex County, New Jersey, offers that confidence through a highly educated talent pool, continuous university‑backed research, and deep...
Even with dental insurance, many Americans still face sizable out‑of‑pocket bills. The article follows 65‑year‑old Russell Anthony, who expects to spend about $2,000 on dental care despite having coverage, illustrating the common "100/80/50" rule and annual benefit caps of $1,000‑$2,000....
